Calliditas Therapeutics (CALT)
(Delayed Data from NSDQ)
$39.99 USD
+1.52 (3.95%)
Updated May 31, 2024 03:59 PM ET
After-Market: $39.00 -0.99 (-2.48%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/15/2024
Time: -- |
6/2024 | $-0.25 | 0.00% |
Earnings Summary
For their last quarter, Calliditas Therapeutics (CALT) reported earnings of -$0.88 per share, missing the Zacks Consensus Estimate of -$0.14 per share. This reflects a negative earnings surprise of 528.57%. Look out for CALT's next earnings release expected on August 15, 2024. For the next earning release, we expect the company to report earnings of -$0.25 per share, reflecting a year-over-year increase of 24.24%.
Earnings History
Price & Consensus
Zacks News for CALT
Novartis (NVS) Presents Positive Data on Rare Kidney Disease Drug
CALT: What are Zacks experts saying now?
Zacks Private Portfolio Services